21st Annual Meeting of the German Drug Utilisation Research Group (GAA), 9th German "Pharmakovigilanztag"
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
20.11.-21.11.2014, Bonn
Abstracts
Meeting Abstract
(14gaa01)
[Full Text]
Absetzen, hinzufügen oder ändern? Dynamik medikamentöser Verordnungen bei älteren multimorbiden Patienten mit Multimedikation in der Hausarztpraxis
von Büdingen F, Beyer M, van den Akker M, Uhlmann L, Gerlach FM, Muth C[Full Text]
Meeting Abstract
(14gaa02)
[Full Text]
Acute myocardial infarction in the elderly: Treatment strategy, adjunctive medications and 28-day-case fatality: The MONICA/KORA Myocardial Infarction Registry
Amann U, Kirchberger I, Heier M, von Scheidt W, Kuch B, Peters A, Meisinger C[Full Text]
Meeting Abstract
(14gaa03)
[Full Text]
ADHD Care in Transition to Adulthood from the Patient Perspective
Schubert I, Buitkamp M, Lehmkuhl G[Full Text]
Meeting Abstract
(14gaa04)
[Full Text]
Adverse drug reactions of the iron chelator deferiprone during mono- and simultaneous combination therapy in Chinese paediatric thalassemia patients
Botzenhardt S, Sing CW, Wong ICK, Chan GCF, Wong LYL, Felisi M, Rascher W, Ceci A, Neubert A[Full Text]
Meeting Abstract
(14gaa05)
[Full Text]
Antihyperglycaemic medication in patients with newly diagnosed diabetes: a long-term claims data analysis
Egen-Lappe V, Köster I, Schubert I[Full Text]
Meeting Abstract
(14gaa06)
[Full Text]
Arzneimittelsicherheit bei Kindern und Jugendlichen – Off-Label Anwendung und Arzneimittelsicherheit von Neuroleptika und Antidepressiva
Dörks M, Blenk T, Tahden M, Garbe E[Full Text]
Meeting Abstract
(14gaa07)
[Full Text]
Aspects of the study design and preliminary results of the WestGem study: WESTphalian study on a medication therapy management and home care based intervention under Gender specific aspects in Elderly Multimorbid patients
Rose O, Waltering I, John C, Mertens-Keller D, Richling I, Mennemann H, Koeberlein-Neu J[Full Text]
Meeting Abstract
(14gaa08)
[Full Text]
Benzodiazepines and Z-drugs: On private prescription or not?
Ludigkeit S, Hempel G, Luhmann E, Puteanus U[Full Text]
Meeting Abstract
(14gaa09)
[Full Text]
Demography and risk factors of severe cutaneous adverse reactions: analysis of the German RegiSCAR-cohort over a period of 10 years
Mockenhaupt M, Hübsch T, Paulmann M, Sekula P[Full Text]
Meeting Abstract
(14gaa10)
[Full Text]
Detecting adverse drug reaction signals based on claims data – a review of the literature
Walker J, Jacob J, Ganninger M[Full Text]
Meeting Abstract
(14gaa11)
[Full Text]
Diabetes Type 2 Registry DIAREG: Using an innovative approach to build a prospective type 2 diabetes registry in primary care practices in Germany
Schröder-Bernhardi D, Bode-Greuel K[Full Text]
Meeting Abstract
(14gaa12)
[Full Text]
Dosing errors of psychotropic drugs – a report of the AMTS of BfArM
Kayser C, Paeschke N[Full Text]
Meeting Abstract
(14gaa13)
[Full Text]
Drug Use Patterns of Elderly Neuroleptic Users in Germany
Schmedt N, Jobski K, Schink T, Garbe E[Full Text]
Meeting Abstract
(14gaa14)
[Full Text]
Drug utilisation patterns in hospitalised children and adolescents: an international perspective
Rashed AN, Botzenhardt S, Wong ICK, Tomlin S, Neubert A[Full Text]
Meeting Abstract
(14gaa15)
[Full Text]
Drug-related Problems in Children and Adolescents – a Prospective Cohort Study on a Paediatric Ward at a University Hospital in Germany
Toni I, Botzenhardt S, Wimmer S, Trollmann R, Rascher W, Neubert A[Full Text]
Meeting Abstract
(14gaa16)
[Full Text]
Drugs with Anticholinergic Effects are Associated with a Reduced Quality of Life and Functionality in Elderly Multimorbid Outpatients receiving Polypharmacy
Hammer MS, Uhlmann L, Beyer M, Gerlach FM, Magin P, Muth C[Full Text]
Meeting Abstract
(14gaa17)
[Full Text]
Evaluation of drug related problems by community pharmacists
Koling S, Waltering I, Hempel G[Full Text]
Meeting Abstract
(14gaa18)
[Full Text]
Frequency of Polypharmacy in Children in Germany
Selke GW, Eichler U, Langner I[Full Text]
Meeting Abstract
(14gaa19)
[Full Text]
Health Care Data in Early Benefit Assessment – What data is suitable?
Bleß HH[Full Text]
Meeting Abstract
(14gaa20)
[Full Text]
Inappropriate Use of DPP-4 Inhibitors
Reichel A, Blank S, Tamminga M, Schoch GG, Steimle T[Full Text]
Meeting Abstract
(14gaa21)
[Full Text]
Incident use of metformin and cancer risk: Results of a matched cohort study
Geier AS, Wellmann J, Wellmann I, Kajüter H, Heidinger O, Hempel G, Hense HW[Full Text]
Meeting Abstract
(14gaa22)
[Full Text]
Interaction of RMP, PSUR and PASS: challenge for the marketing authorization holders
Storz E[Full Text]
Meeting Abstract
(14gaa23)
[Full Text]
Off-Label Prescribing of Respiratory Drugs in Children living in Bavaria (Germany)
Schmiedl S, Fischer R, Ibanez L, Fortuny J, Klungel O, Reynolds R, Gerlach R, Tauscher M, Thürmann P, Hasford J, Rottenkolber M[Full Text]
Meeting Abstract
(14gaa24)
[Full Text]
Potential drug-drug interactions in the elderly: prescribing patterns of German physicians
Langner I, Eichler U, Selke GW[Full Text]
Meeting Abstract
(14gaa25)
[Full Text]
Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in a Population-Based Cohort of Older Family Physician Patients
Endres HG, Kaufmann-Kolle P, Bauer E, Böttner C, Thürmann P[Full Text]
Meeting Abstract
(14gaa26)
[Full Text]
Potentially Inappropriate Medications (PIM) in the acute inpatient geriatric institution of the university hospital Jena
Al-Otti S, Hippius M, Kwetkat A[Full Text]
Meeting Abstract
(14gaa27)
[Full Text]
Quality and use of medication lists in elderly ambulatory patients
Freigofas J, Seidling HM, Brenner H, Saum KU, Haefeli WE[Full Text]
Meeting Abstract
(14gaa28)
[Full Text]
Rebate contracts: reasons not to substitute
Krieg EM, Gradl G, Schulz M[Full Text]
Meeting Abstract
(14gaa29)
[Full Text]
Results of early benefit assessment (AMNOG) and additional treatment costs: is there a relationship?
Herr D, Thürmann PA[Full Text]
Meeting Abstract
(14gaa30)
[Full Text]
Self-reported adverse drug reactions in elderly patients with polypharmacy
Müller I, Thürmann PA, Berger K[Full Text]
Meeting Abstract
(14gaa31)
[Full Text]
Structural changes induced by innovative and expensive drugs
Schuster R, Heidbreder M[Full Text]
Meeting Abstract
(14gaa32)
[Full Text]
Techniker Krankenkasse MedicationCoach for type 2 diabetics – evaluation of the first year
Mühlbauer V, Schoch GG, Schwarz S, Steimle T[Full Text]
Meeting Abstract
(14gaa33)
[Full Text]
The effect of hospital stay on outpatient drug prescription – the evolution from analysis to patient centered care
Fiß T, Grimmsmann T, Sigeneger G, Dolfen S, Möhlmann H[Full Text]
Meeting Abstract
(14gaa34)
[Full Text]
The influence of fall risk increasing drugs (FRIDS) on falls in elderly outpatients
Heckenbach K, Ostermann T, Matthes H[Full Text]
Meeting Abstract
(14gaa35)
[Full Text]
The influence of hospitalisation on the initiation of hypnotics and sedatives – An observation study based on pharmacy claims data
Grimmsmann T, Fiß T, Himmel W[Full Text]